End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | 0.00% | -1.84% | +16.29% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.29% | 3.77B | |
+32.64% | 50.85B | |
+0.17% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.94% | 26.11B | |
-22.15% | 19.13B | |
+8.15% | 13.05B | |
+27.57% | 12.16B | |
+24.63% | 12.08B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent